Insight

Julie Hallet: Guidance on biomarkers gene therapy for NETs

Photo of Julie Hallet from cpd.utoronto.ca

Dec 16, 2024, 19:07

Julie Hallet: Guidance on biomarkers gene therapy for NETs

Julie Hallet, Assistant Professor of Surgery at the University of Toronto, shared a post on X:

“My Top 10 articles of 2024 (cont’d)

Guidance on biomarkers gene therapy for NETs

JAMA Oncology by NANETS and CommNETs

Few are treatment-informing
Most need further research, including NGS, TMB, NETPET score

Which markers do NETologists currently use?

Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs

Authors: Jonathan M. Loree, David Chan, Jennifer Lim, Heather Stuart, Nicolas Fidelman, Jonathan Koea, Jason Posavad, Meredith Cummins, Sarah Doucette, Sten Myrehaug, Boris Naraev, Dale L. Bailey, Andrew Bellizzi, David Laidley, Veronica Boyle, Rachel Goodwin, Jaydi del Rivero, Michael Michael, Janice Pasieka, Simron Singh.”

Julie Hallet: Guidance on biomarkers gene therapy for NETs

Andrew Bellizzi Boris Naraev cancer Dale L. Bailey David Chan David Laidley Heather Stuart JAMA Oncology Janice Pasieka Jason Posavad Jaydi Del Rivero Jennifer Lim Jonathan Koea Jonathan M. Loree Julie Hallet Meredith Cummins Michael Michael NANETS NETologist NETPET NETs NGS Nicolas Fidelman OncoDaily Oncology Rachel Goodwin Sarah Doucette Simron Singh Sten Myrehaug TMB Veronica Boyle

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

Special Coverage